Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Gene expression profiling of human whole blood samples with the Illumina WG-DASL assay.

Winn ME, Shaw M, April C, Klotzle B, Fan JB, Murray SS, Schork NJ.

BMC Genomics. 2011 Aug 15;12:412. doi: 10.1186/1471-2164-12-412.

2.

Gene expression profiling of whole blood: comparison of target preparation methods for accurate and reproducible microarray analysis.

Vartanian K, Slottke R, Johnstone T, Casale A, Planck SR, Choi D, Smith JR, Rosenbaum JT, Harrington CA.

BMC Genomics. 2009 Jan 5;10:2. doi: 10.1186/1471-2164-10-2.

3.

Whole-genome gene expression profiling of formalin-fixed, paraffin-embedded tissue samples.

April C, Klotzle B, Royce T, Wickham-Garcia E, Boyaniwsky T, Izzo J, Cox D, Jones W, Rubio R, Holton K, Matulonis U, Quackenbush J, Fan JB.

PLoS One. 2009 Dec 3;4(12):e8162. doi: 10.1371/journal.pone.0008162.

4.

Gene expression profiling in formalin-fixed, paraffin-embedded tissues using the whole-genome DASL assay.

April CS, Fan JB.

Methods Mol Biol. 2011;784:77-98. doi: 10.1007/978-1-61779-289-2_6.

PMID:
21898214
5.

cDNA targets improve whole blood gene expression profiling and enhance detection of pharmocodynamic biomarkers: a quantitative platform analysis.

Parrish ML, Wright C, Rivers Y, Argilla D, Collins H, Leeson B, Loboda A, Nebozhyn M, Marton MJ, Lejnine S.

J Transl Med. 2010 Sep 25;8:87. doi: 10.1186/1479-5876-8-87.

6.

Genome-wide expression assay comparison across frozen and fixed postmortem brain tissue samples.

Chow ML, Li HR, Winn ME, April C, Barnes CC, Wynshaw-Boris A, Fan JB, Fu XD, Courchesne E, Schork NJ.

BMC Genomics. 2011 Sep 10;12:449. doi: 10.1186/1471-2164-12-449.

7.

Genome-wide comparison of two RNA-stabilizing reagents for transcriptional profiling of peripheral blood.

Nikula T, Mykkänen J, Simell O, Lahesmaa R.

Transl Res. 2013 Mar;161(3):181-8. doi: 10.1016/j.trsl.2012.10.003. Epub 2012 Nov 5.

PMID:
23138105
8.

The effects of globin on microarray-based gene expression analysis of mouse blood.

Winn ME, Zapala MA, Hovatta I, Risbrough VB, Lillie E, Schork NJ.

Mamm Genome. 2010 Jun;21(5-6):268-75. doi: 10.1007/s00335-010-9261-y. Epub 2010 May 16.

9.

Characterization of globin RNA interference in gene expression profiling of whole-blood samples.

Wright C, Bergstrom D, Dai H, Marton M, Morris M, Tokiwa G, Wang Y, Fare T.

Clin Chem. 2008 Feb;54(2):396-405. Epub 2007 Dec 18.

10.

Effects of globin mRNA reduction methods on gene expression profiles from whole blood.

Liu J, Walter E, Stenger D, Thach D.

J Mol Diagn. 2006 Nov;8(5):551-8.

11.

Functional identity of genes detectable in expression profiling assays following globin mRNA reduction of peripheral blood samples.

Field LA, Jordan RM, Hadix JA, Dunn MA, Shriver CD, Ellsworth RE, Ellsworth DL.

Clin Biochem. 2007 Apr;40(7):499-502. Epub 2007 Jan 17.

PMID:
17303101
12.

Interference of globin genes with biomarker discovery for allograft rejection in peripheral blood samples.

Li L, Ying L, Naesens M, Xiao W, Sigdel T, Hsieh S, Martin J, Chen R, Liu K, Mindrinos M, Davis R, Sarwal M.

Physiol Genomics. 2008 Jan 17;32(2):190-7. Epub 2007 Oct 30.

13.

Increased sensitivity of next generation sequencing-based expression profiling after globin reduction in human blood RNA.

Mastrokolias A, den Dunnen JT, van Ommen GB, 't Hoen PA, van Roon-Mom WM.

BMC Genomics. 2012 Jan 18;13:28. doi: 10.1186/1471-2164-13-28.

14.

A practical platform for blood biomarker study by using global gene expression profiling of peripheral whole blood.

Tian Z, Palmer N, Schmid P, Yao H, Galdzicki M, Berger B, Wu E, Kohane IS.

PLoS One. 2009;4(4):e5157. doi: 10.1371/journal.pone.0005157. Epub 2009 Apr 17.

15.

Gene expression profiling of formalin-fixed, paraffin-embedded familial breast tumours using the whole genome-DASL assay.

Waddell N, Cocciardi S, Johnson J, Healey S, Marsh A, Riley J, da Silva L, Vargas AC, Reid L; kConFab Investigators, Simpson PT, Lakhani SR, Chenevix-Trench G.

J Pathol. 2010 Aug;221(4):452-61. doi: 10.1002/path.2728.

PMID:
20593485
16.

Characterization of whole blood gene expression profiles as a sequel to globin mRNA reduction in patients with sickle cell disease.

Raghavachari N, Xu X, Munson PJ, Gladwin MT.

PLoS One. 2009 Aug 3;4(8):e6484. doi: 10.1371/journal.pone.0006484.

17.
18.

Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays.

Wang Y, Barbacioru C, Hyland F, Xiao W, Hunkapiller KL, Blake J, Chan F, Gonzalez C, Zhang L, Samaha RR.

BMC Genomics. 2006 Mar 21;7:59.

19.

Gene expression profiles from formalin fixed paraffin embedded breast cancer tissue are largely comparable to fresh frozen matched tissue.

Mittempergher L, de Ronde JJ, Nieuwland M, Kerkhoven RM, Simon I, Rutgers EJ, Wessels LF, Van't Veer LJ.

PLoS One. 2011 Feb 11;6(2):e17163. doi: 10.1371/journal.pone.0017163.

20.

Variation in RNA-Seq transcriptome profiles of peripheral whole blood from healthy individuals with and without globin depletion.

Shin H, Shannon CP, Fishbane N, Ruan J, Zhou M, Balshaw R, Wilson-McManus JE, Ng RT, McManus BM, Tebbutt SJ; PROOF Centre of Excellence Team.

PLoS One. 2014 Mar 7;9(3):e91041. doi: 10.1371/journal.pone.0091041. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk